J&J, Bayer Pay $775M To Settle Xarelto Litigation

Drug Industry Daily
A A
Johnson & Johnson and Bayer will pay $775 million to settle nearly 25,000 lawsuits alleging that the companies didn’t properly warn the public that their blockbusting blood thinner Xeralto (rivaroxaban) might cause bleeding.

To View This Article:

Login

Subscribe To Drug Industry Daily